FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

896700009: Tafasitamab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4028720015 Tafasitamab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4028721016 Tafasitamab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4028720015 Tafasitamab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4028721016 Tafasitamab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tafasitamab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Tafasitamab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Tafasitamab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafasitamab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only tafasitamab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafasitamab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only tafasitamab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafasitamab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing tafasitamab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tafasitamab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start